Thursday, April 13, 2023

High Importance: Notice and Warning from Mississippi Board of Pharmacy regarding compounding Semaglutide

 

Semaglutide Compounding - Mississippi Board of Pharmacy

2 days ago — The FDA does not typically allow compounding of commercially available drugs unless the drug is not readily available and is listed on the FDA drug shortage .

No comments: